Rochester, NY (PRWEB) July 29, 2014
According to Dr. Lovheim and colleagues, some studies have shown a link between infection with the oral herpes virus (HSV-1) and Alzheimer’s Disease (AD). The doctors wrote that “a sign of reactivated infection (with HSV-1) was found to almost double the risk for AD.” (1) Another study adds to this evidence. “Among the ‘environmental’ risk factors, persistent brain infections, particularly those induced by herpes simplex virus type-1 (HSV-1), seem to play a key role in AD pathogenesis.” (See Frontiers in Pharmacology, from May 2014) (2)
Click to learn more about herpes symptoms.
The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the Center for the Biology of Chronic Disease (CBCD) in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HSV-1, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the (HSV-1 and other viruses)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)
Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.
“Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive decline in cognitive functions leading to memory loss and dementia.” (2)
How does the virus cause AD?
The oral herpes virus that mostly infects a type of cell called an epithelial cell, which is found in the mouth. Once a person is infected the virus replicates, and is using nerves to travel to the brain. Once in the brain, the virus establishes a latent infection. From time to time, the virus travels back to the original site of infection, replicates and causes the well-known clinical lesions (i.e., cold sores and blisters). (2)
In the brain, “it may cause acute neurological disorders like encephalitis [herpes simplex encephalitis (HSE)] or a mild, clinically asymptomatic, infection, or establish life-long latent infection.” (2) The weakening of the immune system, which occurs during aging, only serves to increase the viral damages.
In addition, “Several studies have been performed to assess the presence of HSV-1 in the brain of AD patients…other studies have demonstrated that HSE affected the same brain areas involved in AD in humans as well as in rodent experimental models … (and other studies)… reported that a high proportion (about 60%) of brains of elderly people contained latent HSV-1 DNA, especially in the CNS regions critically involved in AD.” (2) In other words, the virus is repeatedly found in the brains of those who develop Alzheimer’s disease, and in regions typically affected by the disease.
In light of this evidence, the CBCD recommends targeting the latent HSV-1 virus with Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was designed to help the immune system target the latent HSV-1.
All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Lövheim H1, Gilthorpe J2, Adolfsson R3, Nilsson LG4, Elgh F5. Reactivated herpes simplex infection increases the risk of Alzheimer's disease. Alzheimers Dement. 2014 Jul 17. pii: S1552-5260(14)02421-2. ncbi.nlm.nih.gov/pubmed/25043910
(2) HSV-1 and Alzheimer's disease: more than a hypothesis. Published on May 7, 2014. ncbi.nlm.nih.gov/pubmed/24847267
(3) Polansky, H., Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013. cbcd.net/Gene-Eden-VIR-Clinical-Study.php